Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Kerstin A. David"'
Autor:
Annika Spruessel, Garnet Steimann, Mira Jung, Sung A. Lee, Theresa Carr, Anne-Kristin Fentz, Joerg Spangenberg, Carsten Zornig, Hartmut H. Juhl, Kerstin A. David
Publikováno v:
BioTechniques, Vol 36, Iss 6, Pp 1030-1037 (2004)
The aim of this study was to determine the impact of ischemia on gene and protein expression profiles of healthy and malignant colon tissue and, thus, on screening studies for identification of molecular targets and diagnostic molecular patterns. Hea
Externí odkaz:
https://doaj.org/article/70f9eb53bba445498791654841dcac71
Autor:
Nicole Kerstedt, Monika Schoeppler, Bita Motamedi-Baniassad, Antonia Hirt, Julia Ploetzky, Mirja Kastein, Laura Thoms, Malik Khenkhar, Hartmut Juhl, Kerstin A. David
Publikováno v:
Cancer Research. 83:6775-6775
Colorectal cancer (CRC) is one of the most common cancers worldwide and shows heterogenous molecular subtypes making personalized medicine as well as identifying new targets highly important to provide individual patients with the most appropriate tr
Autor:
Nicole Grabinski, Kristina Bernoth, Mirja Piller, Moiken Petersen, Jana Krüger, Olivia Timm, Hartmut Juhl, Kerstin A. David
Publikováno v:
Cancer Research. 79:2128-2128
The goal of personalized medicine is to provide individual patients with the most appropriate treatment. This approach strongly depends on extensive characterization of individual tumors and their sensitivity to therapeutics. We previously have shown
Autor:
Thorsten, Schlomm, Andreas M, Luebke, Holger, Sültmann, Olaf J C, Hellwinkel, Ulrich, Sauer, Annemarie, Poustka, Kerstin A, David, Felix K H, Chun, Alexander, Haese, Markus, Graefen, Andreas, Erbersdobler, Hartwig, Huland
Publikováno v:
International journal of oncology. 27(3)
Molecular analyses of early-stage prostate cancers are necessary to assess their potential clinical significance based on established and/or novel biomarkers for tailored clinical management. A prerequisite for the application of RNA-based analyses o
Autor:
Nicole Lange, Florian T Unger, Monika Schöppler, Katja Pursche, Hartmut Juhl, Kerstin A David
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0133987 (2015)
Correlative studies have identified numerous biomarkers that are individualizing therapy across many medical specialties, including oncology. Accurate interpretation of these studies requires the collection of tissue samples of sufficient quality. Ti
Externí odkaz:
https://doaj.org/article/8dc769c08ada41b2932bdb74b8ed8a36